Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
New Science Ventures
AddedFeb 13, 2024
UpdatedJun 28, 2026
New Science Ventures

New Science Ventures

Operating

New Science Ventures, LLC: A US-based venture capital firm investing in life science and IT sectors.

Location
New York City, NY, US
Founded
2004
Firm
Compare
Portfolio
Employees
Website

New Science Ventures, LLC is a US-based venture capital firm that focuses on investing in both early and late-stage companies within the life sciences and information technology sectors. The firm typically engages in Series A and Series B funding rounds, with additional investments in seed, Series D, Series E, and private equity stages. Their investment strategy targets novel scientific approaches to address significant unmet needs.

Notable portfolio companies include Achronix Semiconductor, Kateeva, and Svelte Medical Systems. The firm is led by key partners who bring extensive experience from their affiliations with leading institutions and companies. New Science Ventures prides itself on creating value through breakthrough science, offering unique value-add services such as strategic guidance and industry connections to help portfolio companies achieve their growth potential.

New Science Ventures - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments32
Current Portfolio Count18
Total Portfolio Exits1

Top Investment Stages

Series A11 (37.9%)
Series B10 (34.5%)
Series Unknown4 (13.8%)
Series D3 (10.3%)
Convertible Note1 (3.4%)

Stage Mix

Series A 38%Series B 34%Series Unknown 14%Series D 10%Convertible Note 3%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Glydways logo

Glydways

VUV Analytics logo

VUV Analytics

Brightvolt logo

Brightvolt

Analog Inference logo

Analog Inference

Phase Four logo

Phase Four

ABL Space Systems logo

ABL Space Systems

Dust Identity logo

Dust Identity

PlanetiQ logo

PlanetiQ

Svelte Medical Systems logo

Svelte Medical Systems

Kateeva logo

Kateeva

Fuzzy Logix logo

Fuzzy Logix

Vorago Technologies logo

Vorago Technologies

Ralexar Therapeutics logo

Ralexar Therapeutics

PerceptiMed logo

PerceptiMed

TigerConnect logo

TigerConnect

Nexeption logo

Nexeption

Resolve Therapeutics logo

Resolve Therapeutics

Achronix Semiconductor logo

Achronix Semiconductor

Juventas Therapeutics logo

Juventas Therapeutics

Proterixbio logo

Proterixbio

New Science Ventures - Classification

Also Known As
  • New Science Ventures, Llc.
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end